Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Low Immunoglobulin G and Low Lymphocyte-Monocyte Ratio at the End of Treatment Predict Early Progression in Diffuse Large B-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 4459.

https://doi.org/10.1182/blood-2024-201850

Published: 2024

Journal Articles

Short Diagnosis to Treatment Interval Is Associated with Poor Outcomes in Relapse or Refractory Diffuse Large B-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 3090.

https://doi.org/10.1182/blood-2024-201328

Published: 2024

Journal Articles

Gnri (Geriatric Nutritional Risk Index) in Multiple Myeloma

Kohei Sato, Kazuhito Suzuki, Riku Nagao, Tadahiro Gunji, Masaharu Kawashima, Hideki Uryu, Mamiko Momoki, Hiroto Ishii, Mitsuji Katori, Susumu Tanoue, Atsushi Katsube, Hiroki Yokoyama, Takeshi Saito, Kaichi Nishiwaki, Shingo Yano

Blood (2024) 144 (Supplement 1): 1939.

https://doi.org/10.1182/blood-2024-203587

Published: 2024

Journal Articles

A Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 3606.

https://doi.org/10.1182/blood-2023-174312

Published: 2023

Journal Articles

The Area Under Tacrolimus Concentrations on Day 14-28 Is the Independent Predictor of the Development of Chronic Gvhd in Patients without Severe Acute Gvhd after Unrelated Allogeneic HSCT

Susumu Tanoue, Hiroki Yokoyama, Hiroto Ishii, Daiki Hattori, Iku Kamitani, Takeshi Saito, Shingo Yano

Blood (2023) 142 (Supplement 1): 2191.

https://doi.org/10.1182/blood-2023-180206

Published: 2023

Journal Articles

Geriatric Nutritional Risk Index Is an Important Predictor of Survival in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Iku Kamitani, Hiroki Yokoyama, Hiroto Ishii, Susumu Tanoue, Daiki Hattori, Takeshi Saito, Shingo Yano

Blood (2023) 142 (Supplement 1): 4968.

https://doi.org/10.1182/blood-2023-185882

Published: 2023

Journal Articles

A Retrospective Comparison of Once-Daily Prolonged-Release Tacrolimus Versus Twice-Daily Tacrolimus in Allogeneic Bone Marrow Transplantation from Unrelated Donors

Shingo Yano, Takeshi Saito, MD, Hiroki Yokoyama, MD, Tomohito Machishimia, MD, Takaki Shimada, MD, Yuichi Yahagi, MD PhD, Shinobu Takahara, MD, Yoji Ogasawara, MD PhD, Katsuki Sugiyama, MD, Jiro Minami, MD, Yutaro Kamiyama, MD, Atsushi Katsube, MD, Noriyuki Morikawa, MD, Kazuhito Suzuki, MD, Yumiko Inui, MD, Noriko Usui, Keisuke Aiba, MD, PhD

Blood (2014) 124 (21): 5867.

https://doi.org/10.1182/blood.V124.21.5867.5867

Published: 2014

Journal Articles

Influence Of Donor Source On Relapse and Survival In Patients With Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis From The Japan Society For Hematopoietic Cell Transplantation (JSHCT) AML Working Group

Shingo Yano, MD, Hiroki Yokoyama, MD, Naoyuki Uchida, MD, PhD, Kazuhiko Kakihana, MD, PhD, Takahiro Fukuda, MD, Heiwa Kanamori, MD, Hiroyasu Ogawa, MD, PhD, Tokiko Nagamura, MD, PhD, Junji Tanaka, MD, PhD, Yasuo Morishima, MD, Yoshiko Atsuta, MD, Akiyoshi Takami, MD, PhD

Blood (2013) 122 (21): 3361.

https://doi.org/10.1182/blood.V122.21.3361.3361

Published: 2013

Journal Articles

Pharmacokinetics for Once-Daily Modified Release Formulation Tacrolimus Hydrate in Unrelated Hematopoietic Stem Cell Transplantation.

Shingo Yano, MD, Shin-ichiro Mori, Takeshi Saito, MD, Hiroki Yokoyama, MD, Tomohito Machishima, Katsuki Sugiyama, MD, Yoji Ogasawara, MD, PhD, Kinuyo Kasama, MD, Noriko Usui, MD, Keisuke Aiba, MD, PhD, Takuya Yamashita, MD

Blood (2012) 120 (21): 3048.

https://doi.org/10.1182/blood.V120.21.3048.3048

Published: 2012

Journal Articles

Standard Administration and Fractionated Administration of Gemtuzumab Ozogamicin for Patients with Relapsed and Refractory Acute Myeloid Leukemia

Yuichi Yahagi, MD, PhD, Noriko Usui, MD, Yuko Yamaguchi, MD, PhD, Nobuaki Dobashi, MD, Shingo Yano, MD, Yutaka Takei, MD, Katsuki Sugiyama, MD, Shinobu Takahara, MD, Yoji Ogasawara, MD, PhD, Takeshi Saito, MD, Kinuyo Kasama, MD, Hiroki Yokoyama, MD, Yutaro Kamiyama, MD, Atsushi Katsube, MD, Keisuke Aiba, MD, PhD

Blood (2012) 120 (21): 4342.

https://doi.org/10.1182/blood.V120.21.4342.4342

Published: 2012

Journal Articles

Prognostic Factors of Reducing Relapse in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation From Related Donor for Acute Myeloid Leukemia: The Japan Society for Hematopoietic Cell Transplantation (JSHCT) AML Working Group

Shingo Yano, MD, Hiroki Yokoyama, MD, Rimei Nishimura, MD, Takahiro Fukuda, MD, Hiroyasu Ogawa, MD, PhD, Kazuteru Ohashi, MD, PhD, Heiwa Kanamori, MD, Junji Tanaka, MD, Hisashi Sakamaki, MD, Yoshiko Atsuta, MD, Akiyoshi Takami, MD PhD

Blood (2011) 118 (21): 3085.

https://doi.org/10.1182/blood.V118.21.3085.3085

Published: 2011

Journal Articles

Clinicopathological Features and Outcome of Der(1;7)(q10;p10) In Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Single-Center Analysis of Japanese Patients

Hiroki Yokoyama, MD, Noriko Usui, MD, Nobuaki Dobashi, MD, Shingo Yano, MD, Yuichi Yahagi, MD, PhD, Yutaka Takei, MD, Katsuki Sugiyama, MD, Yoji Ogasawara, MD, Shinobu Takahara, MD, Yuko Yamaguchi, MD, Takeshi Saito, MD, Takaki Shimada, MD, Fumi Mizorogi, MD, Ken Kaito, MD, Keisuke Aiba, MD

Blood (2010) 116 (21): 1878.

https://doi.org/10.1182/blood.V116.21.1878.1878

Published: 2010

Journal Articles

Impact of T-Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen.

Bungo Saito, MD, Takahiro Fukuda, MD, Hiroki Yokoyama, MD, Saiko Kurosawa, MD, Toshihiro Takahashi, MD, Shigeo Fuji, MD, Noriko Takahashi, Kinuko Tajima, PhD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Yoichi Takaue, MD, Yuji Heike, MD

Blood (2007) 110 (11): 2009.

https://doi.org/10.1182/blood.V110.11.2009.2009

Published: 2007

Journal Articles

Effect of Interventions for Relapse or Progression Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience of 93 Patients.

Saiko Kurosawa, MD, Takahiro Fukuda, MD, Shin-ichiro Mori, MD, Sung-Won Kim, MD, Shigeo Fuji, MD, Bungo Saito, MD, Toshihiro Takahashi, MD, Hiroki Yokoyama, MD, Kinuko Tajima, Ryuji Tanosaki, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2007) 110 (11): 1648.

https://doi.org/10.1182/blood.V110.11.1648.1648

Published: 2007

Journal Articles

Hematopoietic Cell Transplantation (HCT) for Chemoradiotherapy-Related Myelodysplastic Syndrome and Acute Leukemia: A Single-Center Analysis of 47 Patients.

Hiroki Yokoyama, MD, Takahiro Fukuda, MD, Yukio Kobayashi, MD, Sung-Won Kim, MD, Dai Maruyama, MD, Shin-ichiro Mori, MD, Takashi Watanabe, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PHD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2007) 110 (11): 5055.

https://doi.org/10.1182/blood.V110.11.5055.5055

Published: 2007

Journal Articles

Low-Dose ATG-F Reduces Non-Relapse Mortality after Reduced-Intensity Bone Marrow Transplantation from an Unrelated Donor: A Single-Center Analysis of 65 Patients.

Shigeo Fuji, Takahiro Fukuda, Sung-Won Kim, Eiji Usui, Saiko Kurosawa, Hiroki Yokoyama, Bungo Saito, Toshihiro Takahashi, Shin-ichiro Mori, Yuji Heike, Kensei Tobinai, Ryuji Tanosaki, Yoichi Takaue

Blood (2007) 110 (11): 5070.

https://doi.org/10.1182/blood.V110.11.5070.5070

Published: 2007

NARROW

Low Immunoglobulin G and Low Lymphocyte-Monocyte Ratio at the End of Treatment Predict Early Progression in Diffuse Large B-Cell Lymphoma

Short Diagnosis to Treatment Interval Is Associated with Poor Outcomes in Relapse or Refractory Diffuse Large B-Cell Lymphoma

Gnri (Geriatric Nutritional Risk Index) in Multiple Myeloma

A Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation

The Area Under Tacrolimus Concentrations on Day 14-28 Is the Independent Predictor of the Development of Chronic Gvhd in Patients without Severe Acute Gvhd after Unrelated Allogeneic HSCT

Geriatric Nutritional Risk Index Is an Important Predictor of Survival in Allogeneic Hematopoietic Stem Cell Transplant Recipients

A Retrospective Comparison of Once-Daily Prolonged-Release Tacrolimus Versus Twice-Daily Tacrolimus in Allogeneic Bone Marrow Transplantation from Unrelated Donors

Influence Of Donor Source On Relapse and Survival In Patients With Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis From The Japan Society For Hematopoietic Cell Transplantation (JSHCT) AML Working Group

Pharmacokinetics for Once-Daily Modified Release Formulation Tacrolimus Hydrate in Unrelated Hematopoietic Stem Cell Transplantation.

Standard Administration and Fractionated Administration of Gemtuzumab Ozogamicin for Patients with Relapsed and Refractory Acute Myeloid Leukemia

Prognostic Factors of Reducing Relapse in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation From Related Donor for Acute Myeloid Leukemia: The Japan Society for Hematopoietic Cell Transplantation (JSHCT) AML Working Group

Clinicopathological Features and Outcome of Der(1;7)(q10;p10) In Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Single-Center Analysis of Japanese Patients

Impact of T-Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen.

Effect of Interventions for Relapse or Progression Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience of 93 Patients.

Hematopoietic Cell Transplantation (HCT) for Chemoradiotherapy-Related Myelodysplastic Syndrome and Acute Leukemia: A Single-Center Analysis of 47 Patients.

Low-Dose ATG-F Reduces Non-Relapse Mortality after Reduced-Intensity Bone Marrow Transplantation from an Unrelated Donor: A Single-Center Analysis of 65 Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only